• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

水杨酸毒扁豆碱和盐酸毛果芸香碱从不同凝胶制剂中的体外释放研究。

In-vitro study of physostigmine salicylate and pilocarpine hydrochloride release from different gel formulations.

作者信息

Habib F S, Attia M A, el-Shanawany S M

出版信息

Pharmazie. 1986 Feb;41(2):124-5.

PMID:3725852
Abstract

Effect of methylcellulose and polyethylene glycol (PEG1 and PEG2) gel formulations on in-vitro release of combination of 0.25% w/w physostigmine salicylate and 1% w/w pilocarpine hydrochloride was investigated in comparison with a fatty base containing the same drugs by using a stationary dialysis technique. The results showed that the release of both drugs was very slow from the fatty base while a maximum release was attained from methylcellulose gel formulation followed by PEG1 and then PEG2 gel formulations as indicated by the calculated area under curves (AUC) for the amounts of drugs released from different formulations.

摘要

采用静态透析技术,研究了甲基纤维素和聚乙二醇(PEG1和PEG2)凝胶制剂对0.25% w/w水杨酸毒扁豆碱与1% w/w盐酸毛果芸香碱组合体外释放的影响,并与含有相同药物的脂肪性基质进行了比较。结果表明,两种药物从脂肪性基质中的释放非常缓慢,而甲基纤维素凝胶制剂的释放量最大,其次是PEG1凝胶制剂,然后是PEG2凝胶制剂,这由不同制剂释放药物量的计算曲线下面积(AUC)表明。

相似文献

1
In-vitro study of physostigmine salicylate and pilocarpine hydrochloride release from different gel formulations.水杨酸毒扁豆碱和盐酸毛果芸香碱从不同凝胶制剂中的体外释放研究。
Pharmazie. 1986 Feb;41(2):124-5.
2
In vitro evaluation of pluronic F127-based controlled-release ocular delivery systems for pilocarpine.毛果芸香碱基于泊洛沙姆F127的控释眼部给药系统的体外评价
J Pharm Sci. 1998 Feb;87(2):226-30. doi: 10.1021/js970090e.
3
Pluronic F-127 gels as a vehicle for topical formulations of indomethacin and rheological behaviour of these formulations.泊洛沙姆F-127凝胶作为吲哚美辛局部制剂的载体及其制剂的流变学行为。
Pharmazie. 2002 Mar;57(3):186-90.
4
In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride.用于盐酸毛果芸香碱缓释眼部给药的原位凝胶化木葡聚糖制剂。
Int J Pharm. 2001 Oct 23;229(1-2):29-36. doi: 10.1016/s0378-5173(01)00825-0.
5
Determination of pilocarpine, physostigmine, its degradation product rubreserine and preservatives by high-performance liquid chromatography.
J Chromatogr. 1980 Oct 24;198(4):529-33. doi: 10.1016/s0021-9673(00)80526-9.
6
Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of celecoxib through human skin.载体和渗透促进剂对塞来昔布经人体皮肤体外透皮吸收的影响。
Pharmazie. 2003 May;58(5):330-3.
7
Effect of sterilization by autoclaving on the stability of eye drops of pilocarpine hydrochloride and physostigmine sulphate.高压蒸汽灭菌对盐酸毛果芸香碱和硫酸毒扁豆碱滴眼液稳定性的影响。
J Clin Hosp Pharm. 1984 Sep;9(3):217-24. doi: 10.1111/j.1365-2710.1984.tb01079.x.
8
Quantitative determination of pillocarpine in crude drugs, pharmaceutical preparations and with physostigmine in combination.粗药物、药物制剂中毛果芸香碱的定量测定以及与毒扁豆碱联合使用时的定量测定。
Pharmazie. 1975 Jan;30(1):60-1.
9
Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.新型脂质制剂增强了难溶性模型药物吡罗昔康的体外溶出度和通透性特征。
Int J Pharm. 2005 Sep 14;301(1-2):209-16. doi: 10.1016/j.ijpharm.2005.05.032.
10
Evaluation of pilocarpine loaded gelatin particles for topical ophthalmic use.
J Pharm Belg. 1999 May-Jun;54(3):85-6.